Full
Outline
The aim of the article was to provide references for improving the evaluation criteria of medical insurance negotiation admittance for innovative drugs by studying the design and framework of the evaluation criteria of medical insurance negotiation admittance for innovative drugs in typical countries, combined with the current situation in China. The relevant evaluation criteria of New Zealand, Germany, and France were reviewed and summarized, and their characteristics was analyzed and compared with that of China. The reference significance to our country was discussed. Typical countries are more mature in terms of the evaluation system of medical insurance negotiation admittance for innovative drugs, and the diversity of evaluation content, scientificity of evaluation criteria and transparency of negotiation criteria could provide references to our country. It is suggested that China should improve the setting of evaluation criteria from the following aspects: requirement to submit authentic and available cost analysis data for the use of pharmacoeconomic evaluation research, clarifying the evaluation criteria for the varieties of medical insurance negotiation admittance, and establishing good risk control mechanism.
45
7
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
